Global Biomarker Technologies Market was valued at US$ 48 Bn in 2019 and is expected to reach US$ 96.51 Bn by 2027, at a CAGR of 9.12 % during the forecast period.
The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
Global Biomarker Technologies Market
To know about the Research Methodology:-Request Free Sample Report
Global Biomarker Technologies Market Dynamics:
The biomarker is used as a measurable indicator of the severity or presence of some disease state. More generally a biomarker is anything such as gene, biological molecule or characteristic that can be used as an indicator of a particular disease state or some other physiological state of living organism. Biomarker technologies are using in Diagnosis, drug development, and formulation for a contact of definite unsafe chemical and prognostic treatments. The capability of biomarkers to diagnose at an early phase is widely used in cancer analysis and treatment. Biomarkers are using as indicators to estimate and compute pathogenic processes, pharmacological reactions, and biological processes.
Biomarker technologies market is expanding globally under the influence of factors such as increasing incidences of various diseases such as cancer, diabetes, cardiovascular and neurological disorders. National Cancer Institute (NCI) revealed that approximately 13,397,159 people were affected with various cancer types in the United States in 2011. According to the International Diabetes Federation (IDF), nearly 382 million people were living with diabetes from all over the world in 2013 and this number is expected to reach nearly 592 million by the end of 2035. China and India represent the first and second positions with high prevalence of diabetes, 98.4 million and 65.1 million respectively.
The growth of biomarkers market is highly driven by, increasing cases of diseases especially oncology based disease, increasing demand for disease-specific biomarkers,growing adoption of personalized medicine. Moreover, an increasing utility of biomarkers for diagnostic purposes because of its accuracy, increasing healthcare expenditure, FDA support for biomarkers development, the government taking initiative in more biomarker research, increasing R&D funding by biotechnology companies and research institute, these factors will help to drive the market of biomarkers at XX% CAGR during the forecast period.
On the other hand, a huge amount of capital investment required for the discovery of biomarkers, and their development and high cost of biomarkers, this factor may hamper the growth of the biomarkers market during the forecast period.
Global Biomarker Technologies Market Segment Analysis:
Based on product type, the consumables segment accounted for the largest market share of biomarkers in 2019 and is expected to dominate over the others during the forecast period owing to the consumables play a key role in biomarker testing. The consumables market is further segmented into reagents & kits and chromatography columns. In 2019, the reagents & kits segment accounted for the largest share of the consumables market.
By profiling technology, the immunoassay segment accounted for the largest share in 2019 and is expected to drive the market of biomarkers during near future. This segment is further divided into ELISA, protein microarray, and western blot. In 2019, the ELISA segment accounted for the largest share of the immunoassay market. ELISA can quantify levels of multiple proteins and have the potential to accelerate the validation of protein biomarkers simultaneously for clinical use, these factors are helpful for the increasing use of ELISA in conformational studies in biomarker discovery.
The omics technology further divided into proteomics, genetics, and transcriptomics. Omics technology is used in the biomarker discovery technologies market. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting, and other molecular applications. The research area is vaster in omics technology
Global Biomarker technologies Market Regional Insights:
North America held the largest share of the biomarker technologies in 2019 attributed to the increasing prevalence of diseases such as cancer,autoimmune diseases, cardiovascular diseases & neurological diseases, increasing expenditure on health and rising geriatric population, these are the factors responsible for the growth of the biomarker technologies market. Europe had the second-largest market in 2019 and holds a healthy share in the global biomarker technologies market owing to the availability of advanced treatment facilities and established good healthcare infrastructure along with the growing need for efficient and accurate diagnosis and an increasing health expenditure the Asia Pacific is expected to register the highest growth rate from 2019 to 2027 for the biomarker technologies market. The rising incidence of cancer, growing geriatric population, and increasing funds in R&D from private and public organizations for biomarker research, are the factors that will drive the growth of the biomarker technologies market in Asia Pacific region during forecast period.
Recent Highlights in Global Biomarker Technologies Market
A group of chemists from UNSW Sydney’s Australian Centre for Nano Medicine (ACN) and biologists from UNSW's Lowy Cancer Research Centre have created new sensor named “Nano pore blockade sensor” that can detect disease biomarkers in very low concentration in a short time.
The objective of the report is to present comprehensive assessment projections with a suitable set of assumptions and methodology. The report helps in understanding Global Biomarker Technologies Market dynamics, structure by identifying and analyzing the market segments and projecting the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, growth strategies, and regional presence.
for more info:https://www.maximizemarketresearch.com/market-report/global-biomarker-technologies-market/31714/
Scope of the Global Biomarker Technologies Market: Inquire before buying
Global Biomarker Technologies Market, by Test Type
• Solid Biopsy
• Liquid Biopsy
Global Biomarker Technologies Market, by Technology
• ddPCR
• NGS
• Immunoassay
• Mass Spectrometry
• DHPLC
• Other Technologies
Global Biomarker Technologies Market, by Product
• Consumables
• Instruments
• Services
• Software/Informatics
Global Biomarker Technologies Market, by Research
• Genomics
• Proteomics
• Metabolomics
o Metabolic Flux
o Lipidomics
o Others
• Other Research Areas
Global Biomarker Technologies Market, by Application
• Drug Discovery
• Diagnostics
• Personalized Medicine
Global Biomarker Technologies Market, by Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America
Key Players Operating in the Global Biomarker Technologies Market:
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Danaher Corporation
• Agilent Technologies
• Roche
• Waters Corporation
• Shimadzu Corporation
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Merck KGAA
• PerkinElmer Inc.
For More Information Visit @:
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This
report can be personalized to meet your requirements. Get in touch with us and our sales team
will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging
opportunities & technologies as well as threats to the companies across the Healthcare,
Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages,
Aerospace and Defense and other manufacturing sectors.
Biomarker Technologies Market InsightsMarket Research Future has announced its new research report on the global biomarker technologies stating that the market is probable to rise at a CAGR of 9% till the year 2023.
In medicine, a biomarker traces to examine proper functioning of any organ, whereas in cell biology, a biomarker is used for the detection of cellular defects and isolation of a cell type.
Here, the role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described in well version.
Biomarkers, thus, facilitates the combination of therapeutics with diagnostics and plays an important role in the development of personalized medicine.
Nevertheless, the requirement of high capital investments for the discovery, development, and validation of biomarkers are somehow restraining the growth of the biomarker technologies market.Also, on the flip side, factor of high cost of biomarkers are restricting the growth of the biomarker technologies market.Market SegmentationAccording to MRFR, the global biomarker technologies market has been segmented based on product type, profiling technology, disease application, and research areas.By the product type, the market is segmented into consumables, instruments, services, and software/informatics.By profiling technology type, the market is segmented into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies.
Metabolomics is further segmented into lipidomic and others.Regional OutlookOn a geographical note, the global biomarker technologies market has covered main regions of Americas, Europe, Asia Pacific, and the Middle East and Africa.
The new research projects that, the Global Biomarker Technologies Market size will grow from in 2017 to by 2023, at an estimated CAGR.
The base year considered for the study is 2017, and the Biomarker Technologies size is projected from 2018 to 2023.Request Sample PDF @ http://www.orbisresearch.com/contacts/request-sample/2285111Biomarker Technologies Market is strongly guided by following key Players:Biomarker TechnologiesBio-Rad LaboratoriesAdvanced Molecular VisionABT Molecular ImagingBanyan BiomarkersBG MedicineResponse GeneticsVermillionPacific BiomarkersThe report on ‘Biomarker Technologies Market’ is a comprehensive collection of all the market related information required for analyzing and understanding the ‘Biomarker Technologies Market’.
It provides readily available research reports and also cost-effective customized research conducted by their team of experts.By Profiling Technology, Biomarker Technologies Market splits in to following;Chromatography,NGS,PCR,Mass Spectrometry,Immunoassay,Liquid Biopsy (ddPCR, DHPLC)This report on ‘Biomarker Technologies Market’ also gives an analysis of the market segments based on applications, types and key players.
It consists of an elaborate chapter on the competitors dwelling in the ‘Biomarker Technologies Market’.
All this information gives a better understanding of how the ‘Biomarker Technologies Market’ has evolved so far.
Every market research study is based on a methodology which helps segment out the market in a way where every aspect is focused in detail.
Biomarker Technologies Market Information: By Product (Consumables, Instruments), by Profiling Technology (PCR, Imaging Technology, NGS), by Disease Application (Cancer, Infectious Disease), Research Area (Genomics, Proteomics) – Global Forecast Till 2023Market HighlightsThe biomarker technologies market is expected to reach USD 78 Billion by 2023 at a CAGR of 9% during the forecast period.
However, high capital investments required for the discovery, development of biomarkers, and the high cost of biomarkers are restraining the growth of the biomarker technologies market.Regional AnalysisAmericas has the largest market share in the biomarker technologies market.
For instance, the National Cancer Institute (NCI) had stated that 1,666,540 new cases of cancer were reported during 2014 in the United States.
The European market is expected to exhibit a sturdy growth rate during the forecast period owing to the availability of advanced treatment facilities and established healthcare infrastructure, along with the growing need for efficient and accurate diagnosis.
This impact will enhance the biomarker technologies market in Europe.Asia Pacific is expected to be the fastest emerging market.
For instance, in accordance with the International Diabetes Federation, nearly 382 million people had diabetes in 2013 worldwide.
